GW Pharmaceuticals Announces Proposed Public Offering of ADSs
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/13/2026
- S&P 500 futures muted as investors await big bank earnings; chip weakness weighs
- Oil retreats as Russian diesel supply prospects counter Gulf supply risks
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- "Not buying Chipotle": Starbucks squashes blockbuster acquisition speculation
- Bausch + Lomb names Appio interim CEO as Saunders departs
- Cerebras Systems hits new 52-week low on unlock concerns
- Getty Images to go private via prepackaged Chapter 11 restructuring
- Kroger (KR) To Cut Corporate Workforce By About 3,000 Over 3 Years - Bloomberg
- Sysco calls on Teamsters to end LA strike after economic deal reached
GW Pharma (GWPH) to Offer 1.25M ADSs
April 27, 2015 4:02 PM EDTGW Pharmaceuticals plc (Nasdaq: GWPH) announced today that it intends to sell, subject to market and other conditions, 1,250,000 million American Depositary Shares ("ADSs") representing ordinary shares of GW on the NASDAQ Global Market in an underwritten U.S. public offering. GW will grant the... More



